Multiplex gene analysis using nCounter® PanCancer Progression Panel via ROSALINDTM platform, 316 genes showed significant differences between NAT and primary cancer at p-Adj 0.05 with an absolute FC greater than 1.5. Here, BRD2 is linked to cancer.